Skip to content
  • Regions
    • Africa Africa
    • China China
    • Japan Japan
    • MENA MENA
  • Contact
  • Careers
  • Search

Taylor and Francis Logo Taylor and Francis Logo for Print

  • Who we serve
    • Academia
    • Authors
    • Journal authors
    • Book authors
    • Faculty/instructors
    • Librarians
    • Journal editors
    • Industry & government
    • Practitioners
    • R&D professionals
    • Authors
    • Government
    • Healthcare professionals
    • Marketing & brand managers
    • Partners
    • Societies
    • Booksellers
    • Funders
  • Knowledge
    • Medicine & healthcare
    • Education
    • Business & management
    • Psychology
    • Environmental sciences
    • Bioscience
    • Computer & information sciences
    • Mathematics
    • Engineering
    • Civil
    • Electrical
    • Industrial & manufacturing
    • Mechanical
    • Chemical engineering
    • Automotive engineering
    • Energy and oil
    • Materials science research
    • Explore our research portfolio
  • Corporate solutions
    • Pharmaceutical
    • Finance
    • Materials sciences
    • Technology
    • Law
    • Automotive engineering
    • Chemical engineering
    • Energy and oil
    • Defense
  • News
    • Newsroom
    • Insights, analysis, and blogs
    • Events
  • About
    • Company
    • Our brands
    • Executive leadership team
    • Our history
    • Careers
    • Our policies
    • Open research
    • Corporate responsibility
    • Artificial intelligence (AI)
    • Regions
    • Africa
    • China China
    • Japan Japan
    • MENA
    • Contact
    • Careers
I want to publish
a book
in a journal

To find out how to publish or submit your book proposal:

To find a journal or submit your article to a journal:

Medicine, Dentistry, Nursing & Allied Health

Page 156 of 282, total number of terms: 42227

  • Lymphocyte activation
  • Lymphocyte count
  • Lymphocyte-activation gene 3
  • Lymphocytic choriomeningitis
  • Lymphocytic choriomeningitis virus
  • Lymphocytic colitis
  • Lymphocytic hypophysitis
  • Lymphocytic infiltration
  • Lymphocytic interstitial pneumonia
  • Lymphocytic leukemia
  • Lymphocytic pleocytosis
  • Lymphocytopenia
  • Lymphocytosis
  • Lymphoedema
  • Lymphoepithelial lesion
  • Lymphoepithelioma
  • Lymphoepithelioma-like carcinoma
  • Lymphogranuloma venereum
  • Lymphoid cells
  • Lymphoid enhancer-binding factor 1
  • Lymphoid hyperplasia
  • Lymphoid leucosis
  • Lymphoid leukemia
  • Lymphoid progenitor cell
  • Lymphoid tissue
  • Lymphoid tissues
  • Lymphokines
  • Lymphoma
  • Lymphomatoid granulomatosis
  • Lymphomatoid papulosis
  • Lymphopaenia
  • Lymphopenia
  • Lymphoplasmacytic lymphoma
  • Lymphopoiesis
  • Lymphoproliferative disease
  • Lymphoproliferative disorder
  • Lymphoproliferative disorders
  • Lymphoproliferative response
  • Lymphoscintigraphy
  • Lymphotoxin
  • Lymphotoxin alpha
  • Lymphovascular invasion
  • Lynch syndrome
  • Lynch syndrome II
  • Lynestrenol
  • Lys-N
  • Lysergamides
  • Lysergic acid
  • Lysergide
  • Lysergol
  • Lysin
  • Lysine
  • Lysine acetylsalicylate
  • Lysine decarboxylase
  • Lysinuric protein intolerance
  • Lysis
  • Lysis buffer
  • Lysobisphosphatidic acid
  • Lysogenic
  • Lysogenic cycle
  • Lysogeny
  • Lysol
  • Lysophosphatidylcholine
  • Lysophosphatidylethanolamine
  • Lysophosphatidylinositol
  • Lysophosphatidylserine
  • Lysophospholipase
  • Lysosomal
  • Lysosomal storage disease
  • Lysosomes
  • Lysostaphin
  • Lysozyme
  • Lyssavirus
  • Lysyl hydroxylase
  • Lysyl oxidase
  • Lytic cycle
  • Lytta vesicatoria
  • M cells
  • M current
  • M mode echocardiography
  • M protein
  • M1 protein
  • M2 AML
  • M2 protein
  • MA plot
  • MADS-box
  • MAF
  • MAFA
  • MAFB
  • MAFF
  • MALAT1
  • MALBAC
  • MALT
  • MALT lymphoma
  • MAP kinase kinase kinase
  • MAP2K4
  • MAP3K1
  • MAP3K7
  • MAPK phosphatase
  • MAPK1
  • MAPK10
  • MAPK11
  • MAPK14
  • MAPK15
  • MAPK3
  • MAPK8
  • MAPKAPK2
  • MAPKK
  • MARK3
  • MARK4
  • MASP1
  • MASP2
  • MASS syndrome
  • MBD1
  • MBD3
  • MBL deficiency
  • MC1R
  • MC3T3
  • MCF-7
  • MCHC
  • MCM6
  • MCPA
  • MCV
  • MCherry
  • MD
  • MDA-MB-453
  • MDA-MB-468
  • MDA5
  • MDAT
  • MDEA
  • MDMA
  • MDMA-assisted psychotherapy
  • MDPV
  • MDS
  • MDia1
  • MECP2
  • MECP2 duplication syndrome
  • MED1
  • MEF2
  • MEF2B
  • MEF2C
  • MEF2D
  • MEG3
  • MEG8
  • MEGA
  • MEIS1
  • MEK
  • MELAS syndrome
  • MELISA
  • MELK
  • « Previous
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • » Next
Scroll to Top
Explore
  • Our company
  • Our leadership team
  • Careers
  • Contact us
  • Taylor & Francis Online
  • Routledge.com
Our policies
  • Privacy policy
  • Cookies
  • Terms and conditions
  • Accessibility
  • Modern slavery
  • Anti-bribery and corruption
  • Corporate responsibility
  • Gender pay gap report
  • Code of conduct for conference proceedings
Information for
  • Book Authors
  • Journal Authors
  • Librarians
  • Editors
  • Societies
  • Booksellers
  • Press and media
Support
  • Customer support
  • Rights and permissions
  • Royalty recipients
Follow us

Taylor & Francis

 

Informa

 

Routledge

© 2025 Informa plc.

Taylor & Francis is a division of Informa plc

Registered in England & Wales No. 3099067

5 Howick Place | London | SW1P 1WG